Fountainheadinvesting

Categories
Media

Meta Platforms Earnings: A 20% Drop After Hitting the High Bar

Meta Platforms (META)

The bar was too high for Meta to clear.

Post earnings the markets punished it 20% for a marginally weaker guidance and higher than expected CAPEX. Pre-earnings the stock had been up 130% for the past year, so this 20% drop was perhaps, overdue.

Rev beat of 36.46Bn v 36.12Bn 27% YoY – but too little a beat.

Rev guidance 36.5Bn to 39Bn or a midpoint of 37.75 V 38.24,  still 18.5% YoY growth but too much of a miss.

Capex is higher at 37.5Bn midpoint now V 33.5Bn – bad for Meta but good for Nvidia/AI  most of the Capex is for AI.

META has a GAAP operating profit margin of 49% in the family of apps business – that’s a phenomenal margin, but it drops substantially because of losses in the Reality Labs business. Still, its company-wide margin was 38% – a 52% increase YoY.

Will parse through the earnings call/analysts’ upgrades tomorrow morning, the selloff may be overdone.

Categories
Media

Buying Netflix (NFLX): A Bet on Operating Margins and Revenue Growth

There are some fears of the lack of transparency for the next quarters till analysts and investors get used to not seeing subscriber numbers, but operating margins are improving further, revenues are guided to 14% mid-point growth and earnings should increase 25% per year in the next 3. The stock is down 13% from its all-time high.

Netflix Q1-2024

Beats all around, and has better guidance as well.

GAAP EPS of $5.28 beats by $0.76.

Revenue of $9.37B (+14.8% Y/Y) beats by $90M.

Global streaming paid memberships: +9.33M to 269.6M. UP 165 YoY, Q1 is seasonally low, and in Q1-23, the YoY growth was inly 4.9% so this is quite impressive.

Q2 Guidance: Revenue of $9.49B vs. $9.28B consensus, 16% growth, 21% F/X neutral growth.

EPS of $4.68 vs. $4.54 consensus.

For the full year 2024, we expect healthy revenue growth of 13% to 15%, based on F/X rates at the end of Q1’24. 

We now expect an FY24 operating margin of 25%, based on F/X rates as of January 1, 2024, up from our prior forecast of 24%. 

It’s dropped 3% after hours, (of course,)

Categories
Insurance

Globe Life (GL): A Speculative Play on Short Covering and Market Reactions

This is a speculative trade article from an analyst on Seeking Alpha, looking for a short covering bounce, so keep that in mind, when you make your decision.

Globe Life did get a positive report this morning from an analyst, Edward Vranic on Seeking Alpha, suggesting that there would be enough short covering and likely winding up of the speculator’s positions, since they have achieved their short target of $64.

Like most professional short sellers Fuzzy Panda, has used all the alleged corrupt practices at Globe Life to paint a negative picture. As the analyst writes, they didn’t compare it to Primerica, which has a similar problem, and this could be an industry problem.

  • Policies Written for Dead and Fictitious People. 
  • Forged Signatures. 
  • Funds Withdrawn from Consumers’ Bank Accounts without Approval
  • Fictitious Bank Accounts are used to Fund Numerous Fake Policies, so Agents hit their bonuses.

Quoting from the report

  • Fuzzy Panda held a $64.35 price target. GL has dropped below that mark.
  • GL now has valuation metrics well below the industry average and significantly below PRI, it’s most directly comparable as a life insurance company with an MLM sales structure.
  • I believe that the stock price will bounce back to $80 or higher due to short sellers covering their positions and bullish investor speculation.
  • What Fuzzy Panda managed to do was paint GL as a dysfunctional organization filled with frat boys and “crypto bro” types that undertake aggressive sales tactics, show off online, and engage in perverse and questionable behaviors. What it didn’t do is assess how much of this is outside of an industry standard. It wouldn’t be the first time that 25-year-old men out of college bragged about their $100,000 cars, and the company leveraged that as a recruitment tactic. Isn’t the whole point of a growing company to make itself appealing? Should GL be punished for being more honest and upfront about the type of people it believes will do well in selling insurance at its company? If there is something wrong with it, then where are the regulators? Not just over the past five years, for when Fuzzy Panda believes this behavior at GL has accelerated. But over the last 100 years, when a rich lifestyle and fast cars as a financial products sales guru was portrayed as an American dream.
  • The behaviors undertaken by certain employees and management teams of life insurance companies have been unfortunate. However, up until today – and even in the case of GL up until April 11th – few people on Wall Street cared. For whatever reason, the market reaction was quite pronounced on Fuzzy Panda’s report. Even though it was essentially an aggregation of previously disclosed and/or publicly accessible information along with the opinion of a handful of self-proclaimed experts and investigators. I think that reaction went too far, leading to a speculative buying opportunity on GL.
  • Fuzzy Panda and associates will cover their shorts. Short interest was 2.75 million as of March 28th and short-marked volume was over 2.2 million between that date and April 10th. It was over 5 million on April 11th, the day of the report. Some shorts are likely already covered on April 12th. One report shows that a significant put option position was opened, and then closed on the 11th. I believe that momentum will continue into this week as the remaining shorts who shorted high will take their profits, while those who are late to the game and entered in at a low price will be squeezed. I remind readers that Fuzzy Panda’s “generous” target was $64.35. Unlike other short reports I have seen, it did not quantify an impact of any potential restatements of financials nor come up with a target of $0 or close to it. Given the relative softness in terms of price targets compared to other reports I have seen, I believe that this firm will be more likely to take profits than to push the narrative for more gains at a lower price.
  • Therefore, $80 is a reasonable near-term speculative price target on GL and I have positioned myself accordingly.

Here is the link if you want to read the full article.

https://seekingalpha.com/article/4683754-globe-life-betting-on-a-bounce-to-80

Categories
Healthcare

Solventum (SOLV) Stock: A Wait-and-Watch Story Amidst Growth Concerns

Solventum (SOLV) $62.75

Two Wall Street firms Wells Fargo and Morgan Stanley have similar advice to what I gave about Solventum in my earlier post. Growth concerns will keep the stock flat.

It’s a wait-and-watch story.

Here’s the Barron’s link.

https://www.barrons.com/articles/solventum-stock-price-3m-spinoff-4f6025e7?mod=md_stockoverview_news

Categories
Semiconductors

ASML and Lam Research: A Tale of Two Semiconductor Equipment Leaders

Comment made on the SA article.

ASML – Lithography, Monopoly in EUV machines, each machine costs north of $200 Mn, absolutely vital for lower node semis like 3nm, which is powering the latest I-phone among others.

ASML is at the pole position since it’s a critical component for AI and/or high-end chips. Every chip being planned or in production for AI acceleration or incorporating AI acceleration is produced on a 5 nm or smaller node that requires EUV

They also have the lower-end D-EUV machines, which are also successful.

Here’s a good link to the equipment technology market.

https://www.yolegroup.com/strategy-insights/semiconductor-equipment-market-share-reshuffles-amid-memory-demand-decline

Lam Research on the other hand is strong in Etch and Deposition, which is exposed to cyclicality because it’s more of a mass market commodity with competition for AMAT, KLAC, and Tokyo Electronics. But the pickup from customers like Micron, which itself is riding the AI boom for high-grade memory equipment is a big benefit for Lam. To me the biggest strength is the resilience in the last 10 years with an EPS CAGR of 28% – that is a huge deal, cyclicals/commodity producers never get that.

Categories
Finance/banking

JPMorgan Q1 2024 Earnings: Steady Earnings With Higher Loss Provisions

Earnings Season Q1-2024 Big Banks

JP Morgan (JPM)

JPMorgan Chase non-GAAP EPS of $4.63 beats by $0.50, revenue of $41.93B (Up 9.5% YoY) beats by $240M

Q1 -24 Net Interest Income, NII declined 4% sequentially as expected, due to deposit margin compression.

Full Year Net Interest Income, NII guidance is unchanged at $90Bn

Adjusted expenses guidance is $1Bn higher at $91Bn V $90Bn for the year.

The bank card services net charge-off rate is projected to be less than 3.50% vs. its previous guidance of 3.50% – this is a relief, but JPM has a tendency to over provide, so not much of a surprise. Similarly, overall Provision for credit losses was lower at $1.88B, vs. consensus of $2.74B and compared with $2.76B in Q4 and $2.28B in Q1 2023. 

The stock is down 2% premarket, the higher adjusted expense guidance seems to be the main culprit.

Categories
Insurance Stocks

Globe Life (GL): Navigating Short Selling Allegations and Market Volatility

Globe Life (GL) $53

Category – Financial Services – subcategory- insurance

There is a short-selling operation going on by Orso Partners, alleging insurance fraud and of course the usual denials, and the short covering, which caused the 10% bounce premarket.

https://www.cnbc.com/2024/04/11/globe-life-shares-plummet-50percent-after-short-seller-accuses-company-of-insurance-fraud.html

Historically, though higher mortality rates, mostly pandemic related, was one of the main reasons for the drop in 2022 income.

While the balance sheet is relatively OK, debt levels are elevated, which is not ideal in a high-interest rate environment. 

There is a lot depending on declining or increasing mortality rates, and this could cause a lot of volatility in its stock.

That said, the company and analyst estimates are calling for 8% earnings growth in the next 3 years, and if the fraud claims are bogus and just short seller manipulation, the valuation is quite good. It has been a profitable company in the last 5-7 years.

But without enough information on the validity of Orso’s fraud claim it would be difficult to make a call. 

Categories
Finance/banking

Citi Q1 2024 Beats Earnings Estimates

Earnings Season Q1-2024 Big Banks

*Citigroup (NYSE:C): $61.50*

Beats on both earnings and revenues —Q1 GAAP EPS of $1.58 beats by $0.41.

Revenue of $21.1B (-1.6% Y/Y) beats by $700M.

Citi had higher credit card losses but is providing a lower allowance for Q2. – cost of credit was approximately $2.4 billion in the first quarter 2024, compared to $2.0 billion in the prior-year period, primarily driven by higher card net credit losses, partially offset by a lower allowance for credit losses build.

The stock is up 1.5% pre-market.

Categories
Insurance

Globe Life (GL): Navigating Short Selling Allegations and Market Volatility

Globe Life (GL) $53

There is a short selling operation going on by Orso Partners, who’re alleging insurance fraud and of course the usual denials, and the short covering, which caused the 10% bounce premarket.

https://www.cnbc.com/2024/04/11/globe-life-shares-plummet-50percent-after-short-seller-accuses-company-of-insurance-fraud.html

Historically, though higher mortality rates, mostly pandemic related, was one of the main reasons for the drop in 2022 income.

While the balance sheet is relatively OK, debt levels are elevated, which, in a high-interest rate environment, is not ideal. 

There is a lot depending on declining or increasing mortality rates, and this could cause a lot of volatility in its stock.

That said, the company and analyst estimates are calling for 8% earnings growth in the next 3 years, and if the fraud claims are bogus and just short seller manipulation, the valuation is quite good. It has been a profitable company in the last 5-7 years.

But without enough information on the validity of Orso’s fraud’s claim it would be difficult to make a call. 

Categories
Fintech

MoneyLion: A Fintech with Roaring Potential but Credit Risks to Watch

MoneyLion (ML) $76, Fintech

Positives

Diverse base of revenue (subscription fees, interchange, interest, etc.).

Both consumer and fast-growing enterprise segments, with more than 1.1K channel partners, enterprise now accounts for about one-third of its overall revenue.

The online marketplace for third party vendors is a great idea to increase its offering options in areas like insurance, credit cards, and mortgages. At the end of Q4, about 48% of the products used by its customers were from third parties, up from 26% at the end of last year, showing its expanding marketplace.

ML management striving for GAAP profitability should be a positive catalyst.

Ernst & Young, EY partnership is also positive.

Customer acquisition costs are low at $15, they can expand without hurting profits.

Negatives and Risks

The biggest risk is credit – so far it has been under control, but as we’ve seen with Fintech, things start spiraling out of control very fast, without proper guardrails in place.

Credit quality remained steady. Its provision expense as a percentage of total originations was 3.4% for the full year – THIS MUST BE WATCHED FOR DETERIORATION. Management usually warns and expects over 4% of losses so they’re not downplaying the credit risk.

Valuation

112x adjusted earnings per share, with the hope of 300% growth in 2025. Much lower on adjusted earnings. Still high, but if earnings materialize the P/E drops to 26. Clearly the lion needs to roar.

If you have the capacity for some credit risk, this is potentially good and can return in excess of 20% per year.